Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I bioequivalence study of new enarodustat tablet vs current tablet in healthy Japanese males
jRCT2071200037Phase 1Completed
- Sponsor
- Japan Tobacco
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of enarodustat in anemia of renal disease (2 arms), sponsored by Japan Tobacco. Primary endpoint: Bioequivalence of enarodustat between new and current formulations. Started Oct 2020; status: completed.
02
Drugs
enarodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2071200037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200037.